The Indian Pharmaceutical Alliance (IPA), the lobby group which represents large domestic pharmaceutical companies in the country, has given a clean chit to Micro Labs, the makers of Dolo 650 mg which landed in controversy over alleged distribution of freebies to doctors.
The IPA has submitted a report to the Department of Pharmaceuticals (DoP) and National Pharmaceutical Pricing Authority (NPPA) stating that the company was “following the processes as per the Uniform Code of Pharmaceutical Marketing Practices (UCPMP) guidelines” and they did not find any wrong doing. Last month, the NPPA had approached IPA regarding the alleged marketing practices by Micro Labs seeking an investigation.
The IPA’s ethics committee deliberated the matter and came to the conclusion based on the discussion with Micro Labs management and the reply with supporting documents sent by the CMD of Micro Labs. “The alleged complaint is related to marketing expenses and related tax deductions. The IPA Committee thoroughly investigated the marketing practices adopted by the company and whether they are aligned with the UCPMP Code.”
